A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers

Clinical trial NCT01587703 · COMPLETED

Trial details

NCT number: NCT01587703
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Midline

Start date: 2012-03-28
Primary completion: 2018-04-13
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.